• About
  • Services
  • Clients
  • Client News
  • PCG Research
  • PCG Digital
  • Contact
  • follow:

  • 31 Mar

    American Shared Hospital Services Announces Fourth Quarter and Full Year 2024 Earnings Conference Call

    SAN FRANCISCO, March 31, 2025 (GLOBE NEWSWIRE) -- American Shared Hospital Services (NYSE American: AMS) (the "Company"), a leading provider of stereotactic radiosurgery and advanced radiation therapy cancer treatment services, today announced that the Company will hold a conference call to discuss its fourth quarter and full year 2024 financial… Read More..

    Share this:
  • 31 Mar

    Opus Genetics Announces Financial Results for Full Year 2024

    Provides update on the Company’s transformation and promising portfolio of innovative gene therapy treatments for inherited retinal diseases Strong cash position with $21.5 million financing to supplement $30.3 million year-end balance New capital supports delivery on key milestones for two lead gene therapy candidates OPGx-LCA5 and OPGx-BEST1 RESEARCH TRIANGLE PARK,… Read More..

    Share this:
  • 31 Mar

    Aclarion Provides Update on Strength of Company Positioning Following Q1 Strategic Initiatives

    BROOMFIELD, Colo., March 31, 2025 (GLOBE NEWSWIRE) -- Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence (AI) algorithms to help physicians identify the location of chronic low back pain, today provided a corporate update on its strengthened positioning following… Read More..

    Share this:
« Previous 1 … 14 15 16 17 18 … 239 Next »
  • Twitter feed is not available at the moment.
  • QUICK LINKS

    • About
    • Services
    • Clients
    • Client Media
    • PCG Media
    • PCG Research
    • Contact
    • Privacy Policy
    • Disclosures

    FOLLOW US

    Copyright © 2022 PCG Advisory.

    MENU logo
    • About
    • Services
    • Clients
    • Client News
    • PCG Research
    • PCG Digital
    • Contact